Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+22.4%
5Y CAGR+11.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+22.4%/yr
vs +77.9%/yr prior
5Y CAGR
+11.1%/yr
Recent acceleration
Acceleration
-55.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.85M | +22.5% |
| 2024 | $37.42M | +57.1% |
| 2023 | $23.82M | -4.7% |
| 2022 | $25.00M | -4.0% |
| 2021 | $26.05M | -4.0% |
| 2020 | $27.14M | +73.5% |
| 2019 | $15.65M | +527.6% |
| 2018 | $2.49M | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |